P.05.18: Single-Center Experience about Biosimilar Infliximab: Clinical, Pharmacological and Economic Aspects. (15th March 2017) - Geccherle, A.; Tessari, R.; Variola, A.; Massella, A.; Capoferro, E.; Zuppini, T.